Albion

Quick links to important sections

Albion

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Albion

Property Description
Active ingredient Mecobalamin (Methylcobalamin)
Form Oral solids (tablets, capsules) and Injectable solutions
Pharmacological class Vitamin B12 (Cobalamin) / Antianemic preparation (ATC B03BA)
Common role Supporting nerve function and red blood cell formation
Origin Synthetic Coenzyme Derivative

What Type of Medicine is Albion?

Albion is a medicinal preparation centered on the active compound Mecobalamin, which is scientifically identical to Methylcobalamin. It is categorized within the Cobalamin group, collectively known as Vitamin B12, and is formally classified as an Antianemic preparation. Mecobalamin is considered a distinctive form because it functions as one of the biologically active coenzyme forms of the vitamin, allowing for direct use in the body's metabolic processes. This characteristic efficiency is clinically recognized for providing a readily available methyl source compared to non-active precursors like Cyanocobalamin.


Composition and General Purpose

The product's composition relies on Mecobalamin as the sole active ingredient, which is structurally defined as a synthetic coenzyme derivative. Mecobalamin is available in various dosage forms, often including oral solid forms like tablets and parenteral liquid forms intended for injection. This variation in form and administration allows the product to address scenarios ranging from maintenance support (oral route) to more intensive nutritional requirements (parenteral route).

The general purpose of Albion is to supply this essential active coenzyme, which is critical for sustaining key biological reactions. Mecobalamin plays a vital co-factor role in methyl transfer reactions required for DNA synthesis and for maintaining the protective myelin sheath around nerve fibers. Its role is therefore focused on supporting neurological function and hematopoiesis, providing foundational support necessary for managing overall metabolic balance.

What side effects are possible with Albion?

Possible side effects and safety information

The officially documented safety profile for Mecobalamin, the active compound in Albion, details potential adverse reactions categorized by System Organ Class, alongside explicit safety constraints defined in regulatory documents.

Adverse effects are documented across several physiological systems. Reactions affecting the Gastrointestinal disorders system may include nausea, vomiting, diarrhea, and abdominal pain. Effects involving the Skin and subcutaneous tissue disorders are listed and include skin rash, itching, and exanthema. General systemic effects such as headache, dizziness, fever, and malaise have also been reported. For the injectable form, local administration site conditions such as pain, swelling, and redness (erythema) may occur.

Serious Adverse Reactions and Key Constraints

Serious adverse reactions, while rare, have been documented, particularly with the parenteral administration of Vitamin B12 compounds. These include severe allergic reactions like anaphylactic shock, and complications involving the cardiovascular system such as pulmonary edema and congestive heart failure reported early in treatment. The development of hypokalemia (low potassium) and subsequent cardiac arrhythmias is a safety pattern noted at the initiation of intensive therapy for deficiency states.

Official labeling contains specific safety constraints. A critical contraindication prohibits use in individuals with Leber's disease, an inherited optic nerve condition. Furthermore, the potential for specific medications to reduce the absorption of the compound or to attenuate its hematologic effect is noted as an interaction-related safety consideration. Due to the nature of reporting, the official frequency for many listed effects is classified as Not Known.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose Scope: Official Regulatory Information

Classification of Manifestations Officially Documented Outcomes & Requirements
Documented Presentation The compound Mecobalamin is a water-soluble vitamin with low acute toxicity risk, meaning a high probability of rapid excretion and a reduced likelihood of traditional dose-dependent toxicity [NIH StatPearls]. However, severe symptoms may still result from overdose [FDA PI].
Physiological Systems Affected Potential severe outcomes documented in regulatory resources include effects on the cardiovascular system such as Congestive Heart Failure and Vascular Thrombosis, as well as Pulmonary Edema and Hypokalemia (low potassium) [NIH StatPearls].
Emergency Response If an overdose is suspected, an individual must seek medical attention without any delay [FDA PI]. Immediate emergency care is warranted for any manifestation of severe or life-threatening symptoms, such as difficulty breathing or swelling.

Antidote and Management

The regulatory profile explicitly states that no specific antidote is known for cobalamin overdose [NIH StatPearls]. Consequently, the mandated management for overdose situations is restricted to symptomatic and supportive treatment to address the patient’s clinical state and any severe manifestations that may arise. Population-specific overdose risks are not distinctly described in the official labeling.

Connection to the Overall Overdose Profile

The official overdose profile is defined by the drug's inherent low acute toxicity, which contrasts with the necessity to warn about the potential for rare, severe complications. This regulatory approach rigidly dictates that any suspected overdose requires the mandated action to seek medical attention without any delay to ensure prompt access to supportive care.

Therapeutic Uses of Albion

What Albion Treats: Main Uses and Benefits

Albion may be part of symptomatic management across several therapeutic domains. The core purpose is supportive management of discomfort which is considered relevant in contexts involving heightened systemic burden and may contribute to easing the overall symptom load.

Managing Episodic Symptoms

Albion is often applied in clinical settings that involve acute or unstable symptom patterns and is relevant in conditions characterized by episodic or fluctuating manifestations. It provides supportive relief when symptoms appear suddenly or cause heightened distress, and may assist with short-term symptom stabilization. Key benefits may include supporting day-to-day comfort and assisting with maintaining functional stability when symptoms are more noticeable.

Symptomatic Support: For Fluctuating Symptom Patterns

Albion may be applied in addressing symptoms associated with acute episodes and temporary physiological imbalance.

Regulatory References

  1. NIH MedlinePlus overview of Palliative Care

Eligibility and Restrictions for Use

Albion (sulfadimethoxine) is a sulfonamide antimicrobial primarily indicated for treating coccidiosis and certain bacterial infections in animals, including respiratory, urinary tract, and skin infections in dogs and cats.

Its use is governed by a veterinarian, who assesses the animal's overall health and the type of infection being treated. While generally well-tolerated, specific health conditions and allergies preclude its use.


Who Cannot Use Albion?

Albion should not be administered to animals with the following conditions, due to increased risk of toxicity or adverse reactions:

Condition Rationale for Exclusion
Allergy to Sulfonamides Risk of severe hypersensitivity reactions.
Severe Liver Dysfunction Impaired metabolism and risk of toxic accumulation.
Severe Kidney Dysfunction Impaired excretion.
Dehydration Increased risk of crystal or stone formation in the urinary tract.
Pregnancy or Nursing Safety is not established; potential risk to the offspring.
Pre-existing Dry Eye Disease Risk of exacerbation.

Use is also advised against or requires extreme caution in specific breeds like Doberman Pinschers, Samoyeds, and Miniature Schnauzers due to a predisposition to immune-mediated side effects.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interactions associated with Albion (or products containing its specific combination of minerals and Pyridoxine/Vitamin B6) primarily involve enzyme antagonism and altered drug absorption. Patients should be aware of high-level regulatory classifications for certain combinations.


Documented Interaction Summary

Interacting Product Category Specific Medicine(s) Interaction Mechanism/Consequence Regulatory Guidance
Antiparkinson Agents Levodopa Pyridoxine antagonizes the action of Levodopa Combination generally not recommended/avoided
Anticoagulants Aspirin, Heparin, Clopidogrel Pyridoxine component may increase the possibility of bleeding Use with Caution/Monitor
Iron-Containing Products Levodopa/Carbidopa combination Iron may interfere with Levodopa absorption, reducing effectiveness Separate dosing by as much time as possible

Interaction-Related Constraints

Products containing Pyridoxine (a key component in some Albion formulations) are not recommended for use in patients receiving Levodopa alone, as this combination leads to antagonism of the antiparkinson effect. For patients taking Levodopa combined with Carbidopa, this antagonism is typically prevented, provided the total daily dose of Carbidopa is at least 75 mg. Furthermore, to minimize reduced drug effectiveness, the administration of iron-containing products and Levodopa/Carbidopa should be spaced apart.

Mechanism of Action

The Mechanism of Action of Albion (Mecobalamin)

Albion's mechanism is defined by the direct participation of Mecobalamin as an essential coenzyme in fundamental metabolic reactions. The molecule serves as the methyl donor required to activate the enzyme Methionine Synthase (MTR) in the cytoplasm. This activation is critical for catalyzing the conversion of Homocysteine into Methionine, thereby sustaining the methylation cycle.

This core reaction produces two major physiological effects. First, it regenerates Tetrahydrofolate (THF), a molecular precursor necessary for the synthesis of DNA building blocks. This mechanism supports rapid cell proliferation, which is required for normal erythropoiesis (red blood cell production) and the subsequent maturation of blood cells. Second, the production of Methionine is foundational for synthesizing S-adenosylmethionine (SAMe), the universal biological methyl donor. SAMe sustains the required methylation of lipids and proteins for the structural integrity of the myelin sheath surrounding nerve fibers. This action influences the structural integrity and functional conductivity of the central and peripheral nervous systems, alongside influencing circulating metabolite levels.

Dosage and Administration Information

How to Use Albion

The principles governing the use of Albion (Mecobalamin) are defined by its administration route, the prescribed dosage, and a two-phase treatment structure. This medicine is administered either through the oral route (as tablets or sublingual forms) or by parenteral injection, typically intramuscularly (IM). While the intravenous (IV) route is documented, it is noted to result in faster urinary elimination, favoring IM or oral delivery for sustained systemic availability.


Usage is structured as an initial intensive course followed by a long-term maintenance phase. During the initial phase, the injectable form is often administered at a dose of 500 micrograms per injection, typically scheduled three times per week. After this period, the administration shifts to a reduced-frequency maintenance regimen.

For chronic or long-term administration, the oral route is frequently employed. The standard adult dose is 1,500 micrograms daily, often administered in three divided doses. Instructions for proper intake include taking the oral form with or after a meal, depending on the specific product form. Specific procedural rules for the injectable form mandate that the ampoule must be protected from light and that injection sites must be rotated during IM use to avoid local irritation. Dosage adjustments are guided by the treating physician based on the patient’s age and the level of systemic need.

Recent Clinical Evidence

Research evidence / Overview of studies for Albion

Albion, the active form Mecobalamin, was studied for its role in various conditions where nerve health or Vitamin B12 status is relevant. Research typically explores how symptoms change over time and how they are measured using standardized functional and patient-reported outcomes. The findings describe group patterns, not personal outcomes, and should be viewed within the context of the specific study conditions under which they were conducted.


Evidence for use in Diabetic Peripheral Neuropathy

Randomized Controlled Trials (RCTs) have evaluated Mecobalamin in adults with diabetes experiencing mild to moderate nerve symptoms. Researchers monitored outcomes related to physical discomfort and objective nerve function markers. Studies reported changes measured during the observation period in both patient-reported outcomes and objective tests, but findings were mixed regarding the extent of changes in nerve conduction velocity, particularly when studied without other combination therapies. The evidence is limited as follow-up durations were often short, meaning long-term effects are not fully established.

Research on Correcting Vitamin B12 Deficiency

Mecobalamin was examined for correcting diagnosed B12 deficiency in various groups. Studies monitored the correction of biochemical markers, such as methylmalonic acid and homocysteine, and hematologic status. Research highlights changes measured during the study period showing rapid normalization of these markers. The research base is generally highly consistent and supports the recognized role of Mecobalamin as a form of B12 replacement therapy.

What is Still Uncertain in the Research Landscape

The overall evidence landscape highlights significant gaps. Sample sizes were often modest in trials exploring symptomatic support, which potentially limits the broad applicability of the findings. Furthermore, comparative evidence is lacking in large-scale trials directly measuring functional superiority against all other forms of B12 across all indications, leaving the understanding of potential differences less clear.

Key Studies & References

  1. Vitamin B12 Supplementation in Diabetic Neuropathy: A 1-Year, Randomized, Double-Blind, Placebo-Controlled Trial
  2. The efficacy and safety of mecobalamin combined with Chinese medicine injections in the treatment of diabetic peripheral neuropathy: A systematic review and Bayesian network meta-analysis of randomized controlled trials

Frequently Asked Questions (FAQ)

Common questions about Albion (FAQ)

Q: What is the main reason a doctor would prescribe Albion?

Regulatory documents state that Mecobalamin (Albion) is primarily prescribed for the treatment or prevention of Vitamin B12 deficiency. This may also include associated health issues, such as peripheral neuropathy (nerve damage) or certain types of anemia that result from a lack of B12. Its role involves supplying the body with this essential active coenzyme.

Q: Does Albion come in different strengths?

Official product information indicates that Mecobalamin is available in various forms and strengths, reflecting different medical needs. For example, it is regulated and sold in multiple oral strengths, commonly including 500 micrograms (mcg), 1 milligram (mg), and 1.5 mg tablets, in addition to injectable solutions.

Q: How quickly does Albion usually start to work?

Mecobalamin acts quickly to replenish B12 levels in the body, which can cause improvements in blood counts (hematologic response) within a few days. However, official information notes that neurological symptom improvement is generally described as requiring weeks to months of sustained use.

Q: What does 'contraindications' mean in relation to Albion?

A contraindication is a condition or situation where the medicine must not be used because it poses a significant risk of harm. According to official labeling, known hypersensitivity (allergy) to cobalt or Vitamin B12 is a contraindication. The official label notes that this class of medicine is contraindicated in individuals with Leber's disease, an inherited optic nerve condition.

Q: Is it common to feel tired when taking Albion?

While tiredness or fatigue is not listed on all regulatory labels, related general systemic effects such as weakness and malaise (a general feeling of being unwell) have been reported. Official documents often classify the frequency of these effects as 'Not Known,' meaning it is not possible to determine if this symptom is common or uncommon.

Q: Can Albion affect my ability to drive or operate machinery?

Official labeling includes dizziness and malaise among the possible adverse effects. Due to the possibility of these effects, official labeling advises caution regarding driving or operating complex machinery until a patient knows how they respond to the medicine.

Q: Are there any specific foods or drinks to avoid while using Albion?

Yes, regulatory-sourced patient information advises caution with certain substances. Specifically, patients are advised to avoid drinking large amounts of alcohol, as heavy consumption can impair the body's ability to absorb the medicine. Additionally, taking high doses of Vitamin C (ascorbic acid) might lower the available amount of B12.

Q: What is the risk of a serious allergic reaction to Albion?

Serious adverse reactions are documented, although the official frequency is often not classified. Official labeling notes that severe allergic responses, including anaphylactic shock (a life-threatening reaction), have been reported, particularly with the injectable form of Vitamin B12 compounds. Sensitivity to cobalt or B12 is listed as a contraindication.

Q: Can older adults typically use Albion safely?

Yes, older adults are one of the patient populations for which Mecobalamin is commonly prescribed. The official labeling confirms that dosage adjustments are permitted and guided by a physician based on the patient's age and specific systemic requirements.

Q: What do I do if I forget to take my scheduled dose of Albion?

Official instructions typically advise taking the missed dose as soon as it is remembered. However, if it is almost time for the next scheduled dose, the patient should continue the normal routine and not take two doses to compensate for the missed one.

Q: How long can a person usually stay on Albion treatment?

The duration of treatment depends entirely on the underlying condition. For specific chronic conditions, such as pernicious anemia or B12 malabsorption issues, treatment is often described as a long-term commitment or may be needed for life to support nerve health and prevent deficiency recurrence.

Q: Are there any long-term health concerns associated with using Albion?

Based on regulatory reviews, there is no established evidence that long-term use of Mecobalamin in patients with chronic deficiency, such as pernicious anemia, carries carcinogenic (cancer-causing) risk. Long-term use is standard for managing B12 deficiency.

Q: Why do official documents state Albion is not for children?

Official labeling for injectable B12 products carries warnings for use in infants. This is due to the risk associated with certain preservative components, such as Benzyl Alcohol, in premature neonates. Additionally, aluminum accumulation is a risk in premature neonates with impaired kidney function.

Q: Is Albion approved for use in all countries?

Mecobalamin is generally an internationally recognized and approved compound, but specific brand names or higher-dose formulations may only hold regulatory approval for certain indications or dosage schedules in specific countries (e.g., Japan, UK, Canada). Global availability and approved uses vary.

Q: What is the purpose of the 'Black Box Warning' (if any) on Albion's label?

Mecobalamin products typically do not carry a Black Box Warning (the most serious warning label). However, the WARNINGS section does highlight serious risks, including the potential for severe optic atrophy in individuals with Leber's disease and the risk of Hypokalemia (low potassium) at the start of intense therapy.

Q: Why might a patient need to stop taking Albion suddenly?

Stopping the medicine should only be done if instructed by a healthcare provider. A patient may be told to stop immediately if they experience a serious adverse effect, such as a severe allergic reaction (like swelling or anaphylactic shock). Abrupt, unsupervised discontinuation can lead to the return of underlying deficiency symptoms.

Q: Is it normal to have a slight headache when starting Albion?

Official product information, such as drug information sheets from regulatory bodies, includes headache among the commonly reported side effects. Other common effects include nausea and diarrhea. Patients should discuss any persistent or severe symptoms with a healthcare professional.

Q: Can men and women use Albion for the same treatment goals?

Yes, the core purpose of the medicine is to correct Vitamin B12 deficiency, which is not gender-specific. The official product labeling confirms that Albion is used in both men and women for the same core treatment goals of supporting nerve health and red blood cell formation.

Q: Do lifestyle factors like smoking or drinking affect Albion's effectiveness?

Yes, official patient resources state that certain lifestyle choices can impact the medicine. Heavy alcohol consumption can interfere with how the body absorbs Mecobalamin. Research has also indicated that exposure to cigarette smoke may alter the chemical form of the compound.

Q: If I have a history of liver issues, can I still be prescribed Albion?

The official human Mecobalamin label does not list liver disease as a specific contraindication. However, the prescribing physician will consider overall health and may adjust the dose or require monitoring during treatment, as is standard practice for drugs metabolized by the body.

Q: What happens if Albion is taken by someone who shouldn't take it?

One serious risk is associated with a specific contraindication: if an individual with Leber's disease (an inherited optic nerve condition) takes this medicine, they risk suffering severe optic atrophy (vision loss). Taking it despite a known allergy also risks a severe allergic reaction.

Q: How does Albion affect blood test results?

Official labeling notes that using high doses of B12 can produce a false correction of blood counts in patients who are actually deficient in folate (another B vitamin). This can mask the true underlying diagnosis if blood tests are not interpreted carefully by a professional.

Q: Can stopping Albion cause any rebound effects or withdrawal symptoms?

While the drug does not cause classic withdrawal, regulatory documents emphasize the serious consequence of stopping therapy. Failure to continue B12 treatment for conditions like pernicious anemia can result in the return of anemia and may eventually lead to the development of incapacitating and irreversible nerve damage to the spinal cord.

Q: Is Albion a controlled substance?

No, Mecobalamin is generally classified by regulatory bodies as a vitamin (Vitamin B12). It is not classified as a federally controlled substance, though the injectable and high-dose oral forms typically require a prescription.

Q: What clinical trials led to the approval of Albion?

Mecobalamin’s general approval is based on its established nutritional role. Specific high-dose indications may be supported by named trials, such as the JETALS study cited in some regulatory filings, which focused on a specific nerve disease.

Q: Does Albion have potential interactions with common herbal remedies?

Official labeling often advises patients to inform their healthcare professional if they are taking any herbal remedies, supplements, or traditional medications. This is a precaution, as potential interactions with some natural products may exist even if they are not specifically named on the label.

Q: What patient population was Albion originally studied in?

The earliest research and use of B12 therapy, which includes Mecobalamin, focused on correcting Pernicious Anemia. This condition is characterized by a severe inability to absorb B12 from the digestive tract, leading to serious megaloblastic anemia and nerve problems.

Q: Do you need a special prescription for Albion?

This depends on the dose and type of product. Lower-strength oral forms of Mecobalamin are frequently available over the counter as dietary supplements. However, the higher-dose oral products and all injectable solutions generally require a prescription (Rx) from a physician.

Q: How long does Albion stay in your system after the last dose?

Official pharmacokinetics data for the injectable form indicate that the medicine is cleared relatively quickly. After an injection, the majority of the administered dose (up to 98%) is typically excreted in the urine within 48 hours, with the bulk of that happening within the first eight hours.

Q: What are the signs of Albion being less effective over time?

If the medicine is not working or if treatment is insufficient, the underlying B12 deficiency will likely reappear. This is signaled by the return of anemia and the progression or worsening of neurologic symptoms that the medicine was intended to manage.

Q: Is it okay to crush or cut the Albion tablet?

Regulatory instructions typically describe conventional tablets as needing to be swallowed whole and generally should not be chewed, cut, or crushed. Sublingual forms, which dissolve under the tongue, have separate, specific instructions for dissolving, not swallowing.

Q: Can I buy Albion over the counter?

Yes, lower-strength oral Mecobalamin products are commonly sold over the counter in pharmacies and retail stores as dietary supplements. However, higher-dose prescription-only forms and injectable solutions are not available without a prescription.

Q: What should I expect at my first follow-up appointment after starting Albion?

Following regulatory guidelines, follow-up appointments typically involve assessing the body's response. The doctor will monitor the patient’s overall symptoms, as well as require blood tests to check hematologic status (blood counts) and biochemical markers like methylmalonic acid to ensure the deficiency is being corrected.

Q: What happens if I miss several doses of Albion?

Missing multiple doses, especially for a diagnosed deficiency, can result in the return of anemia and the potential progression of nerve damage.

Q: What are the criteria for being considered a 'responder' to Albion in studies?

In clinical trials and official guidelines, being a 'responder' is typically defined by positive, measurable changes. These include the normalization of specific biochemical markers in the blood, correction of anemia, and documented improvement in neurological symptoms over the course of treatment.

Q: Do people who take Albion need special monitoring or tests?

Yes, official labeling indicates that monitoring may be required. This can include regular testing of Vitamin B12 levels, hematologic status (red blood cell counts), and potentially potassium levels (due to the risk of hypokalemia at the start of intense therapy).

Q: Is Albion a biologic drug?

No, the compound Mecobalamin is classified as a synthetic coenzyme derivative and a Vitamin B12 compound (Cobalamin). It is considered a small-molecule drug. It is not classified as a large-molecule biologic medicine.

How should Albion be stored and disposed of?

Official Storage and Disposal Requirements

The storage and disposal instructions for Albion (Mecobalamin) are defined by regulatory documents to protect the product's quality and ensure safety.

Storage Conditions

Albion must be stored under conditions that protect the light-sensitive active ingredient. Storage temperature must not exceed 30 C and the medicine must be protected from both light and excessive heat. It is required to keep the product in the original package and ensure the container is kept tightly closed to guard against moisture.

Stability and Handling

For the injectable solution form, any unused medicine remaining after a dose is administered must be discarded immediately and should not be stored. All forms of Albion must be kept out of the sight and reach of children.

Disposal Rules

Expired or unused Albion should primarily be disposed of using an available drug take-back program. Disposal into wastewater or drains is prohibited. If a take-back program is unavailable, the medicine should be secured and discarded in the household trash, as specified by regulatory guidance.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Albion found in:

A-Z Index: